Pharma Company Behind Controversial Drug Facing DOJ Probe

Pharma Company Behind Controversial Drug Facing DOJ Probe

Acadia Pharmaceuticals is facing a Department of Justice probe over marketing practices related to its controversial Parkinson’s drug Nuplazid (pimavanserin). The investigation was disclosed in an SEC document and was first reported by CNN.

In the filing, the company said it had received a civil investigative demand from the DOJ asking for documents under the False Claims Act. Although which documents the DOJ is seeking has not been disclosed, similar types of inquiries typically look at sales and marketing materials, communications between the company and doctors and payments made to doctors from the company.

The approval of Nuplazid, which is used to treat psychosis – hallucinations and delusions – associated with Parkinson’s, was controversial, as an FDA reviewer said that the risks of the drug didn’t outweigh its benefits. As of April 2018, more than 700 deaths linked to Nuplazid had been reported to an FDA adverse events database since the drug’s approval in 2016. As a result, the FDA conducted an additional evaluation of Nuplazid, but didn’t find any new safety issues with the drug.

Like other atypical antipsychotics, Nuplazid contains a “black box” warning that those with Parkinson’s disease taking the drug have a higher risk of death.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

No Link Found Between H1N1 Vaccine and Autism

No Link Found Between H1N1 Vaccine and Autism

In the quest to discover the causes for Autism Spectrum Disorder (ASD), influenza (H1N1) vaccine can be taken off the chopping block. A recent study out of Sweden, and published in the Annals of Internal Medicine, reported no link between mother’s receiving the H1N1 vaccine while pregnant and their babies…

Diet as Effective as Bariatric Surgery for Managing Blood Sugar (And a lot Safer)

Diet as Effective as Bariatric Surgery for Managing Blood Sugar (And a lot Safer)

For those with Type-2 diabetes, bariatric surgery has been shown by certain studies to have therapeutic effects on metabolic function independent of just weight loss. However, a new study in the New England Journal of Medicine has shown that it is indeed weight loss ls which yields the most dramatic…

  • Advertisement